FIGURE

Fig. 3

ID
ZDB-FIG-220718-26
Publication
Darp et al., 2022 - Oncogenic BRAF induces whole-genome doubling through suppression of cytokinesis
Other Figures
All Figure Page
Back to All Figure Page
Fig. 3

BRAFV600E causes cytokinesis failure by reducing the localization and function of RhoA.

A DAPI and anti-ANILLIN staining in control (−Dox) and BRAFV600E-expressing (+Dox) anaphase RPE-1 cells. Images are maximum intensity projections of z-stacks. Scale bar = 7.5 µM. B Mean ANILLIN fluorescence intensity at the equator of control and BRAFV600E-expressing anaphase RPE-1 cells. N = 79 cells for −Dox and N = 53 for +Dox. Unpaired Student’s t test. Error bars represent mean ± SEM. C DAPI and anti-RHOA staining in -BRAFV600E (−Dox) cells, BRAFV600E-expressing (+Dox) cells, and BRAFV600E-expressing (+Dox) RPE-1 cells treated with MEKi or ERKi. Drugs were added coincident with Dox administration. Images are maximum intensity projections of z-stacks (0.20 µM). Scale bar = 7.5 µM. D Mean RHOA fluorescence intensity at the equator of control RPE-1 cells, BRAFV600E-expressing RPE-1 cells, and BRAFV600E-expressing RPE-1 cells treated with MEKi or ERKi. N = 41 cells for −Dox, N = 68 for +Dox, N = 19 for +Dox +MEKi, and N = 19 for +Dox +ERKi. Brown-Forsythe and Welch one-way ANOVA with Dunnett’s multiple comparisons test. Error bars represent mean ± SEM. E Western blot analysis of immunoprecipitated RHOA-GTP from control (−Dox) and BRAFV600E-expressing (+Dox) RPE-1 cell lysates at different time points post thymidine release. Total RHOA protein and alpha tubulin were used as a controls. A representative of three independent biological replicates is shown. F Western blot quantification of immunoprecipitated RHOA-GTP levels from control (−Dox) and BRAFV600E-expressing (+Dox) RPE-1 cell lysates at different time points post thymidine release. Samples were normalized to the −Dox condition. N = 3 independent experiments. Unpaired Student’s t test. Error bars represent mean ± SEM. G Fold change (FC) in G1 tetraploid RPE-1 FUCCI cells following addition of RHOA activators. LPA (1 µM) and S1P (1 µM) were added coincident with Dox administration. Fold changes in G1 tetraploids relative to the control (+Dox no drug) are shown. N = 3 independent experiments. Unpaired Student’s t test. Error bars represent mean ± SEM. H G1 tetraploid generation following expression of HA-tagged-BRAFV600E in RHOAQ61L-inducible cells. Experimental design (top): RPE-1 FUCCI cells with Dox inducible RHOAQ61L were transiently transfected with an HA-tagged-BRAFV600E-expressing construct and selected accordingly. G1 tetraploids were quantified (bottom left and middle) by gating HA-positive, Cdt-1:mCherry-positive cells with increased Hoechst incorporation. Fold change in G1 tetraploids (bottom right), normalized to control (−Dox) cells. N = 3 independent experiments. Unpaired Student’s t test. Error bars represent mean ± SEM.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Nat. Commun.